These findings imply the possibility that PKD1 could be one of the regulatory factors that contributes to the development of proinflammatory reactions in the joints in susceptible individuals and that PKD inhibitors could be valuable therapeutic options for controlling arthritis. Here, PKD1 is linked to arthritic joint disease.